Immunohistochemical Expression of Granzyme B and Perforin in Discoid Lupus Erythematosus

References

• Vera-Recabarren MA, García-Carrasco M, Ramos-Casals M, Herrero C. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients. Br J Dermatol 2010;162: 91–101
   PubMed Web of Science ®Google Scholar
• Callen JP. Cutaneous lupus erythematosus: a personal approach to management. Australas J Dermatol 2006;47: 13–27
   PubMed Web of Science ®Google Scholar
• Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus 2010;19: 1050–70
   PubMed Web of Science ®Google Scholar
• Rowell NR, Goodfield MJD. The connective tissue diseases. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology, 5th ed. Oxford, UK: Blackwell Scientific, 1992: 2163–225
   Google Scholar
• Durosaro O, Davis MD, Reed KB, Rohlinger AL. Incidence of cutaneous lupus erythematosus, 1965–2005: a population-based study. Arch Dermatol 2009;145: 249–53
   PubMedGoogle Scholar
• Boivin WA, Cooper DM, Hiebert PR, Granville DJ. Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab Invest 2009;89: 1195–220
   PubMed Web of Science ®Google Scholar
• Shah D, Kiran R, Wanchu A, Bhatnagar A. Soluble granzyme B and cytotoxic T lymphocyte activity in the pathogenesis of systemic lupus erythematosus. Cell Immunol 2011;269: 16–21
   PubMed Web of Science ®Google Scholar
• Bolitho P, Voskoboinik I, Trapani JA, Smyth MJ. Apoptosis induced by the lymphocyte effector molecule perforin. Curr Opin Immunol 2007;19: 339–47
   Google Scholar
• Voskoboinik I, Thia MC, Fletcher J, et al. Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: a critical role for aspartate residues 429, 435, 483, and 485 but not 491. J Biol Chem 2005;280: 8426–34
   PubMed Web of Science ®Google Scholar
• Kaiserman D, Buckle AM, Van Damme P, et al. Structure of granzyme C reveals an unusual mechanism of protease autoinhibition. Proc Natl Acad Sci U S A 2009;106: 5587–92
   PubMed Web of Science ®Google Scholar
• Ammar M, Mokni M, Boubaker S, et al. Involvement of granzyme B and granulysin in the cytotoxic response in lichen planus. J Cutan Pathol 2008;35: 630–4
   PubMed Web of Science ®Google Scholar
• Lage D, Pimentel VN, Soares TC, et al. Perforin and granzyme B expression in oral and cutaneous lichen planus—a comparative study. J Cutan Pathol 2011;38: 973–8
   PubMed Web of Science ®Google Scholar
• Yawalkar N, Hunger RE, Buri C, et al. A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis: spongiotic skin lesions in allergic contact dermatitis are highly infiltrated by T cells expressing perforin and granzyme B. Am J Pathol 2001;158: 803–8
   PubMed Web of Science ®Google Scholar
• Batinac T, Zamolo G, Coklo M, Hadzisejdic I. Possible key role of granzyme B in keratoacanthoma regression. Med Hypotheses 2006;66: 1129–32
   PubMed Web of Science ®Google Scholar
• Malyguine AM, Strobl S, Dunham K, et al. ELISPOT assay for monitoring cytotoxic T lymphocytes (CTL) activity in cancer vaccine clinical trials. Cells 2012;1: 111–26
   PubMedGoogle Scholar
• Thiery J, Keefe D, Boulant S, et al. Perforin pores in the endosomal membrane trigger release of endocytosed granzyme B to the cytosol of target cells. Nat Immunol 2011;12: 770–77
   PubMed Web of Science ®Google Scholar
• Cullen SP, Brunet M, Martin SJ. Granzymes in cancer and immunity. Cell Death Differ 2010;17: 616–23
   PubMed Web of Science ®Google Scholar
• Grassi M, Capello F, Bertolino L, et al. Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis. Clin Exp Dermatol 2009;34: 910–14
   PubMed Web of Science ®Google Scholar
• Wenzel J, Uerlich M, Worrenkamper E, et al. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA. Br J Dermatol 2005;153: 1011–15
   PubMed Web of Science ®Google Scholar
• Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002;20: 323–70
   PubMed Web of Science ®Google Scholar
• Herzinger T, Plewig G, Rocken M. Use of sunscreens to protect against ultraviolet-induced lupus erythematosus. Arthritis Rheum 2004;50: 3045–6
   PubMed Web of Science ®Google Scholar
• Millard TP, Hawk JL, McGregor JM. Photosensitivity in lupus. Lupus 2000;9: 3–10
   PubMed Web of Science ®Google Scholar
• Meller S, Winterberg F, Gilliet M, et al. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment, an amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 2005;52: 1504–6
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Cretney E, Takeda K, et al. Tumor-necrosis factor-related apoptosis inducing ligand (TRAIL) contributes to interferon dependent natural killer cell protection from tumor metastasis. J Exp Med 2001;193: 661–70
   PubMed Web of Science ®Google Scholar
• Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003;3: 361–70
   PubMed Web of Science ®Google Scholar
• Pipkin ME, Lieberman J. Delivering the kiss of death: progress on understanding how perforin works. Curr Opin Immunol 2007;19: 301–8
   PubMed Web of Science ®Google Scholar